MedTrace Logo

RPL: Interval to Live Birth and Adverse Perinatal Outcomes

NCT04360564 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140000

Last updated 2023-05-30

No results posted yet for this study

Summary

This will be a retrospective observational cohort study utilizing the data from the British Columbia Perinatal Data Registry (BCPDR). The BCPDR is a provincially inclusive database that aggregates obstetrics and neonatal variables from all attended births in British Columbia.

The primary objective of this study is to evaluate and contrast the average time interval from the first to second birth for patients with recurrent pregnancy loss compared to healthy controls. Secondarily, the investigators will calculate the cumulative live birth rate in the cohort of women with recurrent pregnancy loss who were \</= 35 at age of first birth and delivered between the years 2000-2010. Finally, the investigators will compare the incidence of adverse perinatal outcomes for those with recurrent pregnancy loss and those without.

The results of this study will be valuable for clinicians and patients as it will provide information for prognosis counselling. This will also help those desiring more than one child with long term family planning.

Conditions

  • Abortion, Spontaneous
  • Abortion, Habitual
  • Birth Intervals
  • Pregnancy Loss
  • Pregnancy Complications

Interventions

OTHER

Recurrent pregnancy loss

As described before.

Sponsors & Collaborators

  • Children's & Women's Health Centre of British Columbia

    lead OTHER

Principal Investigators

  • Mohamed A. Bedaiwy, FACOG, FRCSC · University of British Columbia

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-13
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04360564 on ClinicalTrials.gov